Literature DB >> 11553606

Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia.

J Vekemans1, C Lienhardt, J S Sillah, J G Wheeler, G P Lahai, M T Doherty, T Corrah, P Andersen, K P McAdam, A Marchant.   

Abstract

The Mycobacterium tuberculosis antigen ESAT-6 has been proposed for tuberculosis immunodiagnosis. In The Gambia, 30% of community controls produced gamma interferon (IFN-gamma) in response to ESAT-6. Increased proportions of responders and intensities of responses were found in household contacts. Responses that were initially low in tuberculosis patients increased after treatment. An ESAT-6 IFN-gamma assay will be of limited use in the diagnosis of tuberculosis in countries where tuberculosis is endemic. Its role in contact tracing should be evaluated further.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553606      PMCID: PMC98797          DOI: 10.1128/IAI.69.10.6554-6557.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Rationalising tuberculosis contact tracing in low prevalence areas.

Authors:  A G Leitch
Journal:  Respir Med       Date:  1992-09       Impact factor: 3.415

2.  Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection.

Authors:  T Ulrichs; P Anding; S Porcelli; S H Kaufmann; M E Munk
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts.

Authors:  A Demissie; P Ravn; J Olobo; T M Doherty; T Eguale; M Geletu; W Hailu; P Andersen; S Britton
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 4.  The tuberculin skin test.

Authors:  R E Huebner; M F Schein; J B Bass
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

5.  Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians.

Authors:  A Lalvani; P Nagvenkar; Z Udwadia; A A Pathan; K A Wilkinson; J S Shastri; K Ewer; A V Hill; A Mehta; C Rodrigues
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

Review 6.  Specific immune-based diagnosis of tuberculosis.

Authors:  P Andersen; M E Munk; J M Pollock; T M Doherty
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

7.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

8.  Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques.

Authors:  B Schoel; H Gulle; S H Kaufmann
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  The efficacy of the tuberculin test: an analysis based on results from 33 countries.

Authors:  J NYBOE
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

View more
  34 in total

1.  Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination.

Authors:  Mathias Streitz; Stephan Fuhrmann; Fiona Powell; Ali Quassem; Laurel Nomura; Holden Maecker; Peter Martus; Hans-Dieter Volk; Florian Kern
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.

Authors:  Pernille Ravn; Martin E Munk; Ase B Andersen; Bettina Lundgren; Jens D Lundgren; Lars N Nielsen; Axel Kok-Jensen; Peter Andersen; Karin Weldingh
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

4.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.

Authors:  Qi Liu; Xuerong Chen; Chaojun Hu; Renqing Zhang; Ji Yue; Guihui Wu; Xiaoping Li; Yunhong Wu; Fuqiang Wen
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

6.  Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.

Authors:  Anne M Dyrhol-Riise; Gerd Gran; Tore Wentzel-Larsen; Bjørn Blomberg; Christel Gill Haanshuus; Odd Mørkve
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

7.  Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal.

Authors:  Christian Lienhardt; Katherine Fielding; Abdoul A Hane; Aliou Niang; Cheikh T Ndao; Farba Karam; Helen Fletcher; Fatou Mbow; Jules-François Gomis; Raymond Diadhiou; Roger Diadhiou; Maxime Toupane; Tandakha Dieye; Souleymane Mboup
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

Authors:  Helen A Fletcher; Patrick Owiafe; David Jeffries; Philip Hill; Graham A W Rook; Alimuddin Zumla; T Mark Doherty; Roger H Brookes
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.

Authors:  Ilaria Sauzullo; Fabio Mengoni; Miriam Lichtner; Anna Paola Massetti; Raffaella Rossi; Marco Iannetta; Raffaella Marocco; Cosmo Del Borgo; Fabrizio Soscia; Vincenzo Vullo; Claudio Maria Mastroianni
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

10.  Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis.

Authors:  Jean-Louis Herrmann; Marie Belloy; Raphael Porcher; Nancy Simonney; Rola Aboutaam; Muriel Lebourgeois; Joel Gaudelus; Laure De Losangeles; Katarina Chadelat; Pierre Scheinmann; Nicole Beydon; Brigitte Fauroux; Martine Bingen; Mustapha Terki; Dominique Barraud; Philippe Cruaud; Catherine Offredo; Agnes Ferroni; Patrick Berche; Didier Moissenet; Hoang Vuthien; Catherine Doit; Edouard Bingen; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.